<DOC>
	<DOCNO>NCT01067807</DOCNO>
	<brief_summary>Healthy female subject receive single dose four different type Proellex , original 25 mg dose three new formulation</brief_summary>
	<brief_title>Proellex Pharmacokinetics Bridging Study</brief_title>
	<detailed_description>Healthy female subject receive single dose four different type Proellex , original 25 mg dose three new formulation ( 24 50 mg dose ) . Blood collect pre-dose , specified interval 24 hour post dose . Each dose separate least one week interval previous dose .</detailed_description>
	<criteria>Medically normal subject significant abnormal finding screen physical examination evaluate clinical Investigator Subject willing remain clinic screen visit ; treatment visit ( day 1 , day treatment day 1 ; approximately 36 hr per treatment visit ) Postmenopausal woman , Subject document endometriosis Subject know uterine fibroid vaginal polyp</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>